Vanguard Group Inc Geron Corp Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Geron Corp stock. As of the latest transaction made, Vanguard Group Inc holds 29,869,287 shares of GERN stock, worth $135 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,869,287

Previous 28,564,574 4.57%

Holding current value

$135 Million

Previous $60.3 Million 63.54%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.75 - $3.44 $2.28 Million - $4.49 Million	1,304,713 Added 4.57%	29,869,287 $98.6 Million
Q4 2023 Feb 14, 2024	BUY	$1.74 - $2.31 $3.33 Million - $4.42 Million	1,914,328 Added 7.18%	28,564,574 $60.3 Million
Q3 2023 Nov 14, 2023	SELL	$2.11 - $3.28 $69,602 - $108,197	-32,987 Reduced 0.12%	26,650,246 $56.5 Million
Q2 2023 Aug 14, 2023	BUY	$1.97 - $3.69 $8.16 Million - $15.3 Million	4,141,265 Added 18.37%	26,683,233 $85.7 Million
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $7.71 Million - $12.2 Million	3,601,660 Added 19.02%	22,541,968 $48.9 Million

Q4 2022 Feb 10, 2023	BUY	$2.03 - $2.42 $1.41 Million - $1.68 Million	695,155 Added 3.81%	18,940,308 $45.8 Million
Q3 2022 Nov 14, 2022	SELL	$1.67 - $2.94 $2.48 Million - $4.37 Million	-1,485,000 Reduced 7.53%	18,245,153 $42.7 Million
Q2 2022 Aug 12, 2022	BUY	$1.19 - $1.65 $2.85 Million - $3.95 Million	2,393,223 Added 13.8%	19,730,153 $30.6 Million
Q1 2022 May 13, 2022	BUY	$0.99 - $1.6 $1.89 Million - $3.06 Million	1,910,182 Added 12.38%	17,336,930 $23.6 Million
Q4 2021 Feb 14, 2022	BUY	$1.22 - $1.72 $2,785 - $3,926	2,283 Added 0.01%	15,426,748 $18.8 Million
Q3 2021 Nov 12, 2021	SELL	$1.2 - $1.5 $291,451 - $364,314	-242,876 Reduced 1.55%	15,424,465 $21.1 Million
Q2 2021 Aug 13, 2021	BUY	$1.25 - $1.83 $19.6 Million - $28.7 Million	15,667,341 New	15,667,341 $22.1 Million

Others Institutions Holding GERN

# of Institutions

248

Shares Held

374M

Call Options Held

1.48M

Put Options Held

1.18M

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.71B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Geron Corp Transaction History